The purpose of the Unit is to inactivate viruses on medical instruments, which are not subject to disinfection at high temperatures or with the use of aggressive chemicals.  The Unit prevents infection of patients with hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) via medical instruments while undergoing medical procedures. The Unit for inactivation of viruses on medical instruments can be used in medical institutions – public and private hospitals, clinics and medical offices of various profiles and levels. The Unit for inactivation of viruses on medical instruments is protected by a Patent issued by the State Patent Office of the Republic of Uzbekistan, registered in the State Register of Utility Models of the Republic of Uzbekistan in Tashkent under No. IAP 05259 dated 05.23.2014.  

The effectiveness of virus inactivation was proven
  • On inactivation of polio virus vaccine strains – loss of cytopathogenic properties
  • On inactivation of bacteriophages S.typhi – loss of ability to phage S.typhi
  • On inactivation of influenza viruses – loss of cytopathogenic properties
  • On inactivation of the Crimean Congo viruses hemorrhagic fever – loss of cytopathogenic properties
  • On inactivation of the human immunodeficiency virus (HIV) – loss of lymphotropy
  • On inactivation of hepatitis C and B virus – loss of lymphotropy
Unit’s Registration and Certification Documents

 

The State Patent Office of the Republic of Uzbekistan issued a patent on the method for detecting and assessing the viability of lymphotropic viruses, registered in the State Register of utility models of the Republic of Uzbekistan in Tashkent under IAP 04903 dated 06/18/2012.

Currently, European and Eurasian Patent Offices, as well as patent offices of the following countries: China, Korea, Africa, USA, Israel, UAE, India, have accepted patent applications for the invention (method for assessing the viability of lymphotropic viruses).

 

Hotline Phone:  +998 98 300 73 92